Skip Navigation


ToxSci Advance Access originally published online on July 13, 2005
Toxicological Sciences 2005 87(2):409-418; doi:10.1093/toxsci/kfi255
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
87/2/409    most recent
kfi255v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by de Haar, C.
Right arrow Articles by Pieters, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Haar, C.
Right arrow Articles by Pieters, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Ultrafine Carbon Black Particles Cause Early Airway Inflammation and Have Adjuvant Activity in a Mouse Allergic Airway Disease Model

Colin de Haar1, Ine Hassing, Marianne Bol, Rob Bleumink and Raymond Pieters

Department of Immunotoxicology, Institute for Risk Assessment Sciences, Utrecht University, 3584 CM Utrecht, The Netherlands

Received June 13, 2005; accepted July 15, 2005

To gain more insight into the mechanisms of particulate matter (PM)-induced adjuvant activity, we studied the kinetics of airway toxicity/inflammation and allergic sensitization to ovalbumin (OVA) in response to ultrafine carbon black particles (CBP). Mice were exposed intranasally to OVA alone or in combination with different concentrations of CBP. Airway toxicity and inflammation were assessed at days 4 and 8. Immune adjuvant effects were studied in the lung draining peribronchial lymph nodes (PBLN) at day 8. Antigen-specific IgE was measured at days 21 and 28, whereas allergic airway inflammation was studied after OVA challenges (day 28). Results show that a total dose of 200 µg CBP per mouse, but not 20 µg or 2 µg, induced immediate airway inflammation. This 200 µg CBP was the only dose that had immune adjuvant activity, by inducing enlargement of the PBLN and increasing OVA-specific production of Th2 cytokines (IL-4, IL-5, and IL-10). The immune adjuvant activity of 200 µg CBP dosing was further examined. Whereas increased OVA-specific IgE levels in serum on day 21 confirms systemic sensitization, this was further supported by allergic airway inflammation after challenges with OVA. Our data show a link between early airway toxicity and adjuvant effects of CBP. In addition, results indicate that local cytokine production early after exposure to CBP is predictive of allergic airway inflammation. In addition this model appears suitable for studying the role of airway toxicity, inflammation and other mechanisms of particle adjuvant activity, and predicting the adjuvant potential of different particles.

Key Words: ultrafine particles; adjuvant; allergy; intranasal; inflammation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. W. Card, D. C. Zeldin, J. C. Bonner, and E. R. Nestmann
Pulmonary applications and toxicity of engineered nanoparticles
Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L400 - L411.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
F. M. Arantes-Costa, F. D.T.Q.S. Lopes, A. C. Toledo, P. A. Magliarelli-Filho, H. T. Moriya, R. Carvalho-Oliveira, T. Mauad, P. H. N. Saldiva, and M. A. Martins
Effects of Residual Oil Fly Ash (ROFA) in Mice with Chronic Allergic Pulmonary Inflammation
Toxicol Pathol, July 1, 2008; 36(5): 680 - 686.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.